×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
返回 Agenda
Session 9: Use of Artificial Intelligence in Clinical Trial Transparency
Session Chair(s)
Robert Paarlberg, MS
Principal
Paarlberg & Associates LLC, United States
Session 9: Use of Artificial Intelligence in Clinical Trial Transparency
Speaker(s)
![Representative Invited](/_Images/member/Generic_Image_Missing-Profile.jpg)
Leveraging AI Agents to Enhance Clinical Trial Transparency and Efficiency
Representative Invited
Xogene, United States
![Representative Invited](/_Images/member/Generic_Image_Missing-Profile.jpg)
Patient and Public Perceptions on the Use of AI in Creating Clinical Trial Documents
Representative Invited
CISCRP, United States
![Representative Invited](/_Images/member/Generic_Image_Missing-Profile.jpg)
Modernizing the BMS PLS process, accelerating with AI support
Representative Invited
Bristol-Myers Squibb, United States